✦ LIBER ✦

Safety and efficacy of protease inhibitor based combination therapy in a single-center “real-life” cohort of 110 patients with chronic hepatitis C genotype 1 infection

✍ Scribed by Wehmeyer, Malte H; Eißing, Friederike; Jordan, Sabine; Röder, Claudia; Hennigs, Annette; Degen, Olaf; Hüfner, Anja; Hertling, Sandra; Schmiedel, Stefan; Sterneck, Martina; van Lunzen, Jan; Lohse, Ansgar W; zur Wiesch, Julian; Lüth, Stefan

Book ID: 125397922
Publisher: BioMed Central
Year: 2014
Tongue: English
Weight: 342 KB
Volume: 14
Category: Article
ISSN: 1471-230X
DOI: 10.1186/1471-230X-14-87

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of telaprevir, a new

Efficacy and safety of telaprevir, a new protease inhibitor, for difficult-to-treat patients with genotype 1 chronic hepatitis C

✍ N. Hayashi; T. Okanoue; H. Tsubouchi; J. Toyota; K. Chayama; H. Kumada 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

Safety and efficacy of faldaprevir with

Safety and efficacy of faldaprevir with pegylated interferon alfa-2a and ribavirin in Japanese patients with chronic genotype-1 hepatitis C infection

✍ Nishiguchi, Shuhei; Sakai, Yoshiyuki; Kuboki, Makoto; Tsunematsu, Satoshi; Urano 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB

Sa1050 Efficacy of Boceprevir Based Trip

Sa1050 Efficacy of Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1: The PAN Study

✍ Moog, Gero; Mauss, Stefan; Hueppe, Dietrich; Spengler, Ulrich; Schott, Eckart; E 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 315 KB

Efficacy and safety of telaprevir (TVR)

Efficacy and safety of telaprevir (TVR) triple therapy in a ‘real-life’ cohort of 102 patients with HCV genotype 1: interim analysis after 24 weeks of treatment

✍ Werner, C. R.; Franz, C.; Egetemeyr, D. P.; Janke-Maier, P.; Malek, N. P.; Lauer 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Characterization of vaniprevir, a hepati

Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: Safety, antiviral activity, resistance, and pharmacokinetics

✍ Lawitz, Eric; Sulkowski, Mark; Jacobson, Ira; Kraft, Walter K.; Maliakkal, Bened 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 367 KB

1041 EFFICACY AND SAFETY OF ALBINTERFERO

1041 EFFICACY AND SAFETY OF ALBINTERFERON ALFA-2B IN COMBINATION WITH RIBAVIRIN IN TREATMENT- NAIVE, CHRONIC HEPATITIS C GENOTYPE 1 (CHC G1) PATIENTS

✍ Zeuzem, S.; Sulkowski, M.; Lawitz, E.; Rustgi, V.; Lurie, Y.; Grigorescu, M.; Mu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB